← Back
Data updated: Mar 29, 2026
APELLIS PHARMS
Ophthalmology
Pharma
APELLIS PHARMS is a pharmaceutical company focused on Ophthalmology. Key products include EMPAVELI.
2021
Since
2
Drugs
-
Trials
5
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
EMPAVELI 2025-07-28
Efficacy
EMPAVELI 2025-06-10
Labeling
SYFOVRE 2025-03-27
Manufacturing (CMC)
SYFOVRE 2024-12-20
Labeling
EMPAVELI 2024-10-07
REMS
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Ophthalmology 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...